Search for content, post, videos

She is the new CMO at Medivir

The company’s new Chief Medical Officer (CMO) is Pia Baumann. As member of the company's management team her responsibilities include the continued clinical development of the candidate drug fostroxacitabine bralpamide (fostrox), states the company. “I am very pleased that Pia now has take
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.